Healthcare companies listed on the Nigerian Exchange closed the last trading day of 2025 with a cumulative market capitalization of N466.73 billion.
This is an impressive 220.9% increase from their combined N145.4 billion in 2024, showing strong growth in value on the exchange.
Collectively, these companies accounted for 0.47% of the total Nigerian Exchange market, which, as tracked by the All-Share Index, was valued at N99.38 trillion.
The surge in value was fueled by the exceptional performance of these companies, and in 2025, four pharmaceutical firms delivered returns exceeding 100%, closing the year firmly in the green.
One major reason for this strong performance seems to be higher sales of pharmaceutical products, which helped companies that reported nine-month or full-year results post healthier profits in 2025.
Below are the largest health companies on the NGX, covering pharmaceuticals and healthcare services, based on their market capitalization on the last trading day of 2025.
Fidson Healthcare Plc ranks second on the list with a market capitalization of N114.9 billion at the end of 2025, up from N35.5 billion at the close of 2024. The increase in market value was driven by strong share price performance on the NGX.
In 2025, the company’s shares soared 231.5%, rising from around N15 to N50.10, with most of the gain occurring in the second quarter when the stock jumped 143.8%.
- The surge was likely supported by solid financial results, with FY2025 sales up 41.4% to N119 billion, led by ethical pharmaceutical products, which accounted for 65.4% of total sales.
- Profit before tax nearly doubled to N13.8 billion from N7.7 billion in 2024.
This momentum has continued into 2026, lifting the market cap to N179 billion and the share price to N73 — reflecting an early-year gain of over 45%.
